ArticleOncotarget2015

Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.

Hee-Jin Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.